Target intelligence / Profile preview

Gut microbial ecosystem and host intestinal environment

Molecular classification
Other
01

Overview

The gut microbial ecosystem and host intestinal environment represent a complex symbiotic relationship between trillions of microorganisms and the human gastrointestinal tract (NIH, 2023). This system plays a critical role in human health by facilitating the digestion of complex carbohydrates, synthesizing essential vitamins like K and B12, and training the host immune system to distinguish between commensal and pathogenic organisms (PubMed, 2021). The host environment provides a specialized niche, including the mucus layer and antimicrobial peptides, which regulate microbial colonization and prevent systemic translocation (Nature, 2022). Dysregulation of this ecosystem, known as dysbiosis, is linked to a wide range of local and systemic diseases, including inflammatory bowel disease (IBD), metabolic syndrome, and Clostridioides difficile infections (Mayo Clinic, 2023). Therapeutic interventions targeting this environment range from broad-spectrum antibiotics and targeted anti-inflammatories to the introduction of beneficial live organisms or fecal microbiota transplantation (FMT) (StatPearls, 2023). Understanding the interplay between microbial metabolites, such as short-chain fatty acids, and host receptors is a major frontier in drug development and personalized medicine (Science, 2022).

Other names
Gut microbiotaIntestinal microbiomeGastrointestinal ecosystemGut-host interfaceIntestinal microflora
02

Mechanism of action

Modulation of microbial composition, restoration of commensal diversity, inhibition of pathogenic bacterial growth, and reduction of mucosal inflammation.

03

Biological functions

Nutrient metabolismImmune response modulationIntestinal barrier maintenanceVitamin synthesisPathogen colonization resistanceBile acid metabolism
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeObesityType 2 diabetesClostridioides difficile infectionColorectal cancerNonalcoholic fatty liver disease
05

Safety considerations

Risk of systemic infection from probiotics in immunocompromised patientsAntibiotic-induced dysbiosisDevelopment of antimicrobial resistancePathogen transfer via fecal microbiota transplantation (FMT)
06

Interacting drugs

Vancomycin

8 more in the full profile.

07

Biomarkers

Microbial alpha diversityFecal calprotectinShort-chain fatty acids (SCFAs)ZonulinTrimethylamine N-oxide (TMAO)

Beyond the preview

Go deeper on Gut microbial ecosystem and host intestinal environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbial ecosystem and host intestinal environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call